How British research could hold the key to taming Monkeypox and fridge-free vaccines

Stablepharma’s CEO is amongst 29 of London’s Most Impressive & Successful Directors in the Biotech Space

A new generation of COVID-19 vaccines – the latest developments from preclinical and clinical trials?

Stablepharma Ltd has achieved a scientific breakthrough, demonstrating that a fridge-free Tetanus diphtheria (Td) vaccine is possible

Stablepharma Ltd welcomes another new member to the UK Team

Daniela Maria Briceño Garcia joins the Stablepharma Science Team

Fridge-Free Covid-19 Vaccines a Possibility with Stablepharma Technology

Stablepharma’s mission to eliminate the cold chain – an interview by Health Tech World

Stablepharma and BB-NCIPD Ltd (Bul Bio) Accelerate Vaccine Development with Collaboration

Stablepharma completes the first close of Series A raise with £2 million following a number of high-profile partnership announcements

Alan Boyd, of Boyd Consultants & Advisor to Stablepharma, talks about his work, collaborations and the impact of the Pandemic

Özgür Tuncer CEO talks about Developing Thermostable Vaccines To Improve Accessibility Worldwide